Nigeria HIV Infections Surge 2026 as 20,838 new cases are reported, prompting government investment in healthcare and prevention programmes

Nigeria has recorded a total of 20,838 new HIV infections between January and March 2026, with Lagos and Benue states emerging as the most affected, according to data from the National Data Repository.

Also read: WHO Rolls Out Lenacapavir to Curb HIV in Africa

Lagos State reported the highest number of new cases at 2,298, followed by Benue State with 1,949. Akwa Ibom ranked third with 1,159 infections, while Rivers and Anambra recorded 1,137 and 1,013 cases respectively, highlighting a significant spread across multiple regions.

In northern Nigeria, Kaduna State recorded 842 cases, while Kano State reported 476. Other states with notable figures include Delta, Oyo, Ogun, Plateau, Imo, and Nasarawa, each contributing several hundred cases to the national total.

The Federal Capital Territory recorded 579 infections, while Abia and Edo reported 527 and 512 cases respectively. Lower figures were observed in Ebonyi, Gombe, Borno, Ekiti, Sokoto, and Yobe, with Yobe recording the lowest at 100 cases.

The rising figures have come amid renewed government efforts to strengthen public health response and funding.

The Federal Government recently announced a $346 million co-financing commitment for 2026 to support HIV, tuberculosis, and malaria interventions across the country.

Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, disclosed the funding during the national rollout of Lenacapavir, a long-acting injectable used in HIV prevention.

He noted that the investment reflects Nigeria’s increasing reliance on domestic resources to complement global health support.

Prof. Muhammad Ali Pate explained that the funds would be directed toward essential areas such as medical supplies, laboratory surveillance, reagents, primary healthcare expansion, and financial protection mechanisms for citizens.

He emphasised that strengthening these systems is critical to sustaining progress in disease control.

He also acknowledged the shifting global funding landscape, noting that international health financing has become more constrained.

According to him, this development is prompting Nigeria to adopt more innovative and efficient approaches to healthcare delivery.

Also read: Seyi Makinde HIV/AIDS Funding Boosts Oyo Fight with N45m Support

The introduction of advanced preventive tools like Lenacapavir, alongside increased funding commitments, is expected to enhance Nigeria’s capacity to manage HIV and related diseases while supporting broader public health objectives.